Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system

Transfusion

Volumn 53, Issue 7, 2013, Pages 1429-1441

  Freimanis, Graham ^a   Sedegah, Mary ^a   Owusu Ofori, Shirley ^a   Kumar, Sanjai ^a   Allain, Jean Pierre ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

ADULT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

EID: 84880226372     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03943.x     Document Type: Article

References (59)

1. WHO. World malaria report 2010. 2010. [cited 2011 Aug 8]. Available from: URL: http://www.who.int/entity/malaria/world-malaria-reort-2010/ worldmalariareport2010.pdf
2. Owusu-Ofori AK, Parry C, Bates I,. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010; 51: 1192-1198.
3. Allain JP,. Malaria and transfusion: a neglected subject coming back to the forefront. Clin Infect Dis 2010; 51: 1199-1200.
4. Oniyangi O, Omari AA,. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev 2006;(4): CD003489.
5. Noranate N, Durand R, Tall A, Marrama L, Spiegel A, Sokhna C, Pradines B, Cojean S, Guillotte M, Bischoff E, Ekala MT, Bouchier C, Fandeur T, Ariey F, Patarapotikul J, Le Bras J, Trape JF, Rogier C, Mercereau-Puijalon O,. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. Plos ONE 2007; 2: e139.
6. Beshir KB, Hallett RL, Eziefula AC, Bailey R, Watson J, Wright SG, Chiodini PL, Polley SD, Sutherland CJ,. Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malar J 2010; 9: 312-321.
7. Doolan DL, Dobano C, Baird JK,. Acquired immunity to malaria. Clin Microbiol Rev 2009; 22: 13-36.
8. Warhurst DC, Williams JE,. ACP Broadsheet no. 148. July 1996. Laboratory diagnosis of malaria. J Clin Pathol 1996; 49: 533-538.
9. MalERA Consultative Group on Diagnoses and Diagnostics. A research agenda for malaria eradication: diagnoses and diagnostics. Plos Med 2011; 8: e1000396.
10. Lefrere JJ,. [The BOTIA project ("Blood and Organ Transmissible Infectious Agents"): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation]. Transfus Clin Biol 2005; 12: 93-94.
11. Ghana Health Service. Ghana health service report 2010. 2010. [cited 2012 Jun 16]. Available from: URL: http://www.ghanahealthservice.org/documents
12. Owusu-Ofori AK, Bates I,. Impact of inconsistent policies for transfusion-transmitted malaria on clinical practice in Ghana. PLoS ONE 2012; 7: e34201.
13. Abonuusum A, Owusu-Daako K, Tannich E, May J, Garms R, Kruppa T,. Malaria transmission in two rural communities in the forest zone of Ghana. Parasitol Res 2011; 108: 1465-1471.
14. Urbaniak GC, Plous S,. Research randomizer (version 3.0) [Computer software]. 2011. [cited 2010 Oct 29]. Available from: URL: http://www. randomizer.org/
15. Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, Ocran J, Adu-Amankwah S, Geneshan H, Abot E, Legano J, Banania G, Sayo R, Brambilla D, Kumar S, Doolan DL, Rogers WO, Epstein J, Richie TL, Sedegah M,. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J 2011; 10: 168-185.
16. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN,. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993; 58: 283-292.
17. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA,. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 1999; 60: 687-692.
18. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K,. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 2004; 42: 5636-5643.
19. Sanchez JL, Storch GA,. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 2002; 40: 2381-2386.
20. Magesa SM, Mdira KY, Farnert A, Simonsen PE, Bygbjerg IC, Jakobsen PH,. Distinguishing Plasmodium falciparum treatment failures from re-infections by using polymerase chain reaction genotyping in a holoendemic area in northeastern Tanzania. Am J Trop Med Hyg 2001; 65: 477-483.
21. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G,. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 2003; 68: 133-139.
22. Atroosh WM, Al-Mekhlafi HM, Mahdy MA, Saif-Ali R, Al-Mekhlafi AM, Surin J,. Genetic diversity of Plasmodium falciparum isolates from Pahang, Malaysia based on MSP-1 and MSP-2 genes. Parasit Vectors 2011; 4: 233-239.
23. Anderson TJ, Su XZ, Bockarie M, Lagog M, Day KP,. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 1999; 119 (Pt 2): 113-125.
24. Greenhouse B, Myrick A, Dokomajilar C, Woo JM, Carlson EJ, Rosenthal PJ, Dorsey G,. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg 2006; 75: 836-842.
25. Marks F, Evans J, Meyer CG, Browne EN, Flessner C, von, Kalckreuth V, Eggelte TA, Horstmann RD, May J,. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Antimicrob Agents Chemother 2005; 49: 1101-1105.
26. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE,. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A 2009; 106: 18883-18889.
27. Falade CO, Nash O, Akingbola TS, Michael OS, Olojede F, Ademowo OG,. Blood banking in a malaria-endemic area: evaluating the problem posed by malarial parasitemias. Ann Trop Med Parasitol 2009; 103: 383-392.
28. Chattopadhyay R, Majam VF, Kumar S,. Survival of Plasmodium falciparum in human blood during refrigeration. Transfusion 2010; 51: 630-635.
29. Allain JP, Sarkodie F, Boateng P, Asenso K, Kyeremateng E, Owusu-Ofori S,. A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa. Transfusion 2008; 48: 735-741.
30. Nebie KY, Olinger CM, Kafando E, Dahourou H, Diallo S, Kientega Y, Domo Y, Kienou K, Ouattara S, Sawadogo I, Ky L, Muller CP,. [Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security]. Transfus Clin Biol 2007; 14: 446-452.
31. Tagny CT, Diarra A, Yahaya R, Hakizimana M, Nguessan A, Mbensa G, Nebie Y, Dahourou H, Tapko JB, Shiboski C, Murphy E, Lefrere JJ,. [The transfusion center, the blood donor and the given blood in francophone African countries]. Transfus Clin Biol 2009; 16: 431-438.
32. She RC, Rawlins ML, Mohl R, Perkins SL, Hill HR, Litwin CM,. Comparison of immunofluorescence antibody testing and two enzyme immunoassays in the serologic diagnosis of malaria. J Travel Med 2007; 14: 105-111.
33. Owusu-Agyei S, Smith T, Beck HP, Amenga-Etego L, Felger I,. Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health 2002; 7: 421-428.
34. Owusu-Agyei S, Asante KP, Adjuik M, Adjei G, Awini E, Adams M, Newton S, Dosoo D, Dery D, Agyeman-Budu A, Gyapong J, Greenwood B, Chandramohan D,. Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J 2009; 8: 220-230.
35. Browne EN, Frimpong E, Sievertsen J, Hagen J, Hamelmann C, Dietz K, Horstmann RD, Burchard GD,. Malariometric update for the rainforest and savanna of Ashanti region, Ghana. Ann Trop Med Parasitol 2000; 94: 15-22.
36. Mahajan B, Zheng H, Pham PT, Sedegah MY, Majam VF, Akolkar N, Rios M, Ankrah I, Madjitey P, Amoah G, Addison E, Quakyi IA, Kumar S,. Polymerase chain reaction-based tests for pan-species and species-specific detection of human Plasmodium parasites. Transfusion 2012; 52: 1949-1956.
37. Igbeneghu C, Odaibo AB, Olaleye DO,. Impact of asymptomatic malaria on some hematological parameters in the Iwo community in Southwestern Nigeria. Med Princ Pract 2011; 20: 459-463.
38. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Barrell B, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002; 419: 498-511.
39. Murray CK, Gasser RA Jr, Magill AJ, Miller RS,. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008; 21: 97-110.
40. Erhabor O, Ok O, Awah I, Uko KE, Charles AT,. The prevalence of Plasmodia parasitemia among donors in the Niger delta of Nigeria. Trop Doct 2007; 37: 32-34.
41. Boyd MF, Kitchen SF,. On the homogeneity of Plasmodium vivax infections acquired in highly endemic regions. Am J Trop Med Hyg 1948; 28: 29-34.
42. Shekalaghe S, Alifrangis M, Mwanziva C, Enevold A, Mwakalinga S, Mkali H, Kavishe R, Manjurano A, Sauerwein R, Drakeley C, Bousema T,. Low density parasitemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania. BMC Infect Dis 2009; 9: 69-75.
43. Noubouossie D, Tagny CT, Same-Ekobo A, Mbanya D,. Asymptomatic carriage of malaria parasites in blood donors in Yaounde. Transfus Med 2012; 22: 63-67.
44. Talabiska DG, Komar MJ, Wytock DH, Rubin RA,. Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol 1996; 91: 376-379.
45. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA,. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999; 319: 16-19.
46. Hartman TK, Rogerson SJ, Fischer PR,. The impact of maternal malaria on newborns. Ann Trop Paediatr 2010; 30: 271-282.
47. Robinson T, Campino SG, Auburn S, Assefa SA, Polley SD, Manske M, MacInnis B, Rockett KA, Maslen GL, Sanders M, Quail MA, Chiodini PL, Kwiatkowski DP, Clark TG, Sutherland CJ,. Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients. PLoS ONE 2011; 6: e23204.
48. Rajab JA, Waithaka PM, Orinda DA, Scott CS,. Analysis of cost and effectiveness of pre-transfusion screening of donor blood and anti-malarial prophylaxis for recipients. East Afr Med J 2005; 82: 565-571.
49. Hanscheid T, Grobusch MP,. How useful is PCR in the diagnosis of malaria? Trends Parasitol 2002; 18: 395-398.
50. Ali MS, Kadaru AM,. In vitro processing of donors' blood with quinine for elimination of malaria parasites. Saudi Med J 2006; 27: 986-991.
51. Chico RM, Chandramohan D,. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. Trop Med Int Health 2011; 16: 774-785.
52. Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Asahi H, Akao N, Wilson MD, Boakye DA, Ohta N,. Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based combination therapy deployment. Trop Med Int Health 2011; 16: 1215-1224.
53. Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Osei JH, Asahi H, Ofori MF, Akao N, Wilson MD, Boakye DA, Ohta N,. Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malar J 2011; 10: 187-195.
54. Nakornchai S, Konthiang P,. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop 2006; 100: 185-191.
55. Chico RM, Chandramohan D,. Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin Drug Metab Toxicol 2011; 7: 1153-1167.
56. Mufti NA, Erickson AC, North AK, Hanson D, Sawyer L, Corash LM, Lin L,. Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC. Biologicals 2010; 38: 14-19.
57. Marschner S, Goodrich R,. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011; 38: 8-18.
58. Sullivan J, Bounngaseng AS, Reddy HL, Keil SD, Goodrich RP,. Pathogen inactivation of plasmodium falciparum in plasma and platelet concentrates with riboflavin and UV light. [abstract] Vox Sang 2008; 95: 278.
59. Goodrich RP, Doane S, Reddy HL,. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38: 20-30.